HERB-PARTITIONED MOXIBUSTION AND ACUPUNCTURE FOR THE TREATMENT OF ACTIVE CROHN'S DISEASE:A RANDOMIZED CONTROLLED TRIAL

被引:0
|
作者
Huangan Wu [1 ]
Chunhui Bao [2 ]
Huirong Liu [1 ]
Jimeng Zhao [2 ]
Yuan Lu [2 ]
Yifang Zhu [2 ]
Yin Shi [1 ]
Zhijun Weng [1 ]
Hui Feng [3 ]
Xin Guan [4 ]
Jing Li [5 ]
Weifeng Chen [6 ]
Luyi Wu [7 ]
Xiaoming Jin [8 ]
Chuanzi Dou [1 ]
机构
[1] Shanghai Institute of Acupuncture-Moxibustion and Meridian
[2] Shanghai University of Traditional Chinese Medicine
[3] Shanghai Guanghua Hospital of Integrated Chinese and Western Medicine
[4] Shuguang Hospital,Shanghai University of Traditional Chinese Medicine
[5] Yueyang Hospital of Integrated Traditional Chinese and Western Medicine,Shanghai University of Traditional Chinese Medicine
[6] Zhongshan Hospital,Fudan University
[7] Qigong Institute,Shanghai University of Traditional Chinese Medicine
[8] Stark Neurosciences Research Institute,Indiana University School of Medicine
关键词
HERB-PARTITIONED MOXIBUSTION AND ACUPUNCTURE FOR THE TREATMENT OF ACTIVE CROHN’S DISEASE;
D O I
暂无
中图分类号
R246.1 [内科];
学科分类号
100512 ;
摘要
Background: Acupuncture and moxibustion are often used as an alternative therapy for Crohn’s disease(CD), however, their efficacy are not fully established.Objective: This study sought to evaluate the clinical efficacy and safety of acupuncture and moxibustion for the treatment of active CD of mild to moderate severity.Methods: Ninety-two patients were equally and randomly divided into a treatment group that received herb-partitioned moxibustion combined with acupuncture and a control group that received wheat bran-partitioned moxibustion combined with shallow acupuncture.The patients received 3 treatment sessions per week for 12 weeks, and were followed up at the 24 th week.The outcomes were measured by using the CD Activity Index(CDAI) score, lab tests, endoscopic rating, and intestinal histology.Results: The CDAI scores of both the treatment and control groups were significantly reduced after treatment compared to that prior to treatment, but the improvement of the treatment group was significant better than that of the control group.The symptom improvement in patients of the treatment group was sustained at the follow-up, while that of the control group was not.Both groups showed significantly improvement in quality of life ratings after treatments, but the improvement was significantly better in the treatment group than in the control group.In addition, the patients in the treatment group showed significantly increased hemoglobin and decreased C-reactive protein and histopathological scores at the end of the treatment, while the control group did not show any changes.Conclusion: Acupuncture and moxibustion are effective and safe treatment methods for mild to moderate CD.In addition to the placebo effect, acupuncture also has significant therapeutic effects.
引用
收藏
页码:222 / 222
页数:1
相关论文
共 50 条
  • [41] Certolizumab Pegol for Active Crohn's Disease: A Placebo-Controlled, Randomized Trial
    Sandborn, William J.
    Schreiber, Stefan
    Feagan, Brian G.
    Rutgeerts, Paul
    Younes, Ziad H.
    Bloomfield, Ralph
    Coteur, Geoffroy
    Guzman, Juan Pablo
    D'Haens, Geert R.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2011, 9 (08) : 670 - U84
  • [42] Combined budesonide and antibiotic therapy for active Crohn's disease: a randomized controlled trial
    Steinhart, AH
    Feagan, BG
    Wong, CJ
    Vandervoort, M
    Mikolainis, S
    Croitoru, K
    Seidman, E
    Leddin, DJ
    Bitton, A
    Drouin, E
    Cohen, A
    Greenberg, GR
    GASTROENTEROLOGY, 2002, 123 (01) : 33 - 40
  • [43] An antibiotic regimen for the treatment of active Crohn's disease: A randomized, controlled clinical trial of metronidazole plus ciprofloxacin
    Prantera, C
    Zannoni, F
    Scribano, ML
    Berto, E
    Andreoli, A
    Kohn, A
    Luzi, C
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 1996, 91 (02): : 328 - 332
  • [44] Combined budesonide and antibiotic therapy for active Crohn's disease: A randomized controlled trial
    Steinhart, AH
    Feagan, BG
    Greenberg, GR
    Wong, CJ
    Vandervoort, M
    Mikolainis, S
    Croitoru, K
    Seidman, EG
    Leddin, DJ
    Drouin, E
    Bitton, A
    Cohen, A
    GASTROENTEROLOGY, 2001, 120 (05) : A126 - A127
  • [45] A controlled trial comparing ciprofloxacin with mesalazine for the treatment of active Crohn's disease
    Colombel, JF
    Lémann, M
    Cassagnou, M
    Bouhnik, Y
    Duclos, B
    Dupas, JL
    Notteghem, B
    Mary, JY
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 1999, 94 (03): : 674 - 678
  • [46] Efficacy of herb-partitioned moxibustion at Qihai (CV 6) and bilateral Tianshu (ST 25) on colonic damage and the TLR4/NF-κB signaling pathway in rats with Crohn's disease
    Zhang Dan
    Wei Kai
    Ma Xiaopeng
    Wu Huangan
    Hong Jue
    Zhang Cuihong
    Wu Lingxiang
    Yan Huang
    Liu Jie
    Zhu Yi
    Yang Ling
    JOURNAL OF TRADITIONAL CHINESE MEDICINE, 2018, 38 (02) : 218 - 226
  • [47] Acupuncture and moxibustion for incomplete adhesive intestinal obstruction: A randomized controlled trial
    Zhang, Lihua
    Zhang, Shu
    Yan, Pengjing
    Zhang, Zhiguo
    Xie, Suchun
    WORLD JOURNAL OF ACUPUNCTURE-MOXIBUSTION, 2019, 29 (03) : 174 - 178
  • [48] Acupuncture and moxibustion for incomplete adhesive intestinal obstruction:A randomized controlled trial
    张丽华
    张姝
    闫捧敬
    张志国
    谢素春
    WorldJournalofAcupuncture-Moxibustion, 2019, 29 (03) : 174 - 178
  • [49] Efficacy of herb-partitioned moxibustion at Qihai(CV 6) and bilateral Tianshu(ST 25) on colonic damage and the TLR4/NF-κB signaling pathway in rats with Crohn's disease
    Zhang Dan
    Wei Kai
    Ma Xiaopeng
    Wu Huangan
    Hong Jue
    Zhang Cuihong
    Wu Lingxiang
    Yan Huang
    Liu Jie
    Zhu Yi
    Yang Ling
    Journal of Traditional Chinese Medicine, 2018, 38 (02) : 218 - 226
  • [50] Efficacy of acupuncture and moxibustion in treating Bell’s palsy: a multicenter randomized controlled trial in China
    李瑛
    梁繁荣
    余曙光
    李常度
    胡玲香
    周东
    袁秀丽
    李怡
    夏晓红
    中华医学杂志(英文版), 2004, (10) : 61 - 65